RVPH (Reviva Pharmaceuticals Holdings) FCF Yield %: -229.71 (As of Jun. 28, 2026)


RVPH Reviva Pharmaceuticals Holdings Inc RVPH
26 GF Score
Price $0.67
! 1 Warning Sign
View Full Analysis

What is Reviva Pharmaceuticals Holdings FCF Yield %?

Reviva Pharmaceuticals Holdings RVPH +11.80% 26 FCF Yield % is -229.71 as of Jun. 28, 2026. GuruFocus rates RVPH with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 1,418 Biotechnology companies, Reviva Pharmaceuticals Holdings ranks worse than 95.98% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Reviva Pharmaceuticals Holdings's Trailing 12-Month Free Cash Flow is $-20.20 Mil, and Market Cap is $8.79 Mil. Therefore, Reviva Pharmaceuticals Holdings's FCF Yield % for today is -229.71%.

The historical rank and industry rank for Reviva Pharmaceuticals Holdings's FCF Yield % or its related term are showing as below:

RVPH' s FCF Yield % Range Over the Past 10 Years
Min: -229.71   Med: 0   Max: 0
Current: -229.71


RVPH's FCF Yield % is ranked worse than
95.98% of 1418 companies
in the Biotechnology industry
Industry Median: -9.715 vs RVPH: -229.71

Reviva Pharmaceuticals Holdings's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Reviva Pharmaceuticals Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Reviva Pharmaceuticals Holdings FCF Yield % Related Terms


Reviva Pharmaceuticals Holdings FCF Yield % Historical Data

* Premium members only.

The historical data trend for Reviva Pharmaceuticals Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reviva Pharmaceuticals Holdings FCF Yield % Chart

Reviva Pharmaceuticals Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial -25.56 -21.83 -19.70 -39.79 -75.05

Reviva Pharmaceuticals Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.52 -77.38 -62.96 -70.77 -162.65

RVPH vs MLEC, DRMA, MTNB: FCF Yield % Comparison

For the Biotechnology subindustry, Reviva Pharmaceuticals Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reviva Pharmaceuticals Holdings FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reviva Pharmaceuticals Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Reviva Pharmaceuticals Holdings's FCF Yield % falls into.


RVPH
26GF Score
Reviva Pharmaceuticals Holdings Inc RVPH
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reviva Pharmaceuticals Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Reviva Pharmaceuticals Holdings's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-24.595 / 32.77134
=-75.05%

Reviva Pharmaceuticals Holdings's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.801 * 4 / 9.347457
=-162.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -229.71 mean?
Reviva Pharmaceuticals Holdings (RVPH) has a FCF Yield % of -229.71 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Reviva Pharmaceuticals Holdings and its competitors. According to the industry distribution chart, Reviva Pharmaceuticals Holdings ranks #1361 out of 1418 companies in the Biotechnology industry, placing it in the top 96%.
Is Reviva Pharmaceuticals Holdings' FCF Yield % too high?
Reviva Pharmaceuticals Holdings' current FCF Yield % is -229.71. Based on the distribution chart, Reviva Pharmaceuticals Holdings ranks #1361 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Reviva Pharmaceuticals Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Reviva Pharmaceuticals Holdings' FCF Yield % compare to MLEC and DRMA?
According to the Biotechnology industry distribution chart, Reviva Pharmaceuticals Holdings ranks #1361 out of 1418 companies for FCF Yield %. This places Reviva Pharmaceuticals Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Reviva Pharmaceuticals Holdings and its competitors. Reviva Pharmaceuticals Holdings's current FCF Yield % is -229.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reviva Pharmaceuticals Holdings stock overvalued right now?
Reviva Pharmaceuticals Holdings (RVPH) has a current FCF Yield % of -229.71. The current FCF Yield % is -229.71. Reviva Pharmaceuticals Holdings' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Reviva Pharmaceuticals Holdings (RVPH), the current FCF Yield % is -229.71 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reviva Pharmaceuticals Holdings Business Description

Address 10080 North Wolfe Road, Suite SW3-200, Cupertino, CA, USA, 95014
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063), which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis, and its other drug candidate is RP1208.
26GF Score

Get the complete analysis for RVPH

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price